• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK INRANGE; PROTHROMBIN TIME MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK INRANGE; PROTHROMBIN TIME MONITOR Back to Search Results
Catalog Number 07404379016
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/26/2023
Event Type  malfunction  
Manufacturer Narrative
The strip lot number and expiration date were requested but were not provided.The meter and strips have been requested for return.The product has not been received at this time.If the product is returned in the future, a follow-up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." per product labeling: anti-phospholipid antibodies (apa) like lupus antibodies (la) may cause falsely prolong coagulation times.(false-high inr values /false-low %quick values).Where apa are known to be present or suspected, testing with the coaguchek has to be discontinued until discussed with the patient´s physician.E3 - occupation was patient/consumer.
 
Event Description
There was an allegation of questionable results from the coaguchek inrange meter.The result from the meter was 6 or 7 inr.The result from an unknown point of care (poc) device was 3 inr.The result from a laboratory using an unknown reagent was 2.8 inr.The therapeutic range was 2.5-3.5 inr.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK INRANGE
Type of Device
PROTHROMBIN TIME MONITOR
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17938753
MDR Text Key325718942
Report Number1823260-2023-03303
Device Sequence Number1
Product Code GJS
Combination Product (y/n)Y
Reporter Country CodeAU
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number07404379016
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/26/2023
Initial Date FDA Received10/16/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-